Perimenopause can feel like an uphill battle when your body starts changing in ways you didn’t expect. Fluctuating estrogen and progesterone levels often slow your metabolism, making it easier to gain weight around the midsection even if your diet and exercise routine haven’t changed. If you’ve tried cutting calories or ramping up workouts without lasting results, a targeted, medically guided approach might be the missing piece. That’s where Nalena comes in, a telehealth weight loss platform designed specifically for women facing the hormonal shifts of perimenopause, menopause, and postmenopause.
In this article, you’ll learn how GLP-1 medications like semaglutide and tirzepatide can support steady, sustainable weight loss, what to expect from Nalena’s personalized program, and how it compares to more general telehealth options. By the end, you’ll have a clearer picture of whether Nalena is the right choice for your perimenopause weight journey.
Understanding perimenopause weight gain
Perimenopause marks the transition before menopause, often beginning in your early to mid-forties. Changing hormone levels can slow your resting metabolic rate by making your cells less efficient at burning energy. As a result, you may notice extra pounds creeping onto your frame even though you’re eating and moving the way you always have.
It’s not your fault.
Stress, poor sleep, and age can compound this metabolic slowdown, making it feel impossible to lose weight. You might find that the strategies that once worked – like trimming carbs or hitting the treadmill – no longer deliver the same results. Without targeted support that addresses these hormonal changes, many women feel frustrated and stuck.
Exploring GLP-1 medications for weight loss
GLP-1 receptor agonists mimic a natural hormone called glucagon-like peptide-1, which your body releases after eating to help regulate hunger and blood sugar. By activating the same pathways, medications such as semaglutide and tirzepatide can offer a metabolic boost precisely when perimenopausal shifts make appetite and glucose control more challenging.
- Regulate your appetite by sending “I’m full” signals to your brain
- Slow down gastric emptying so meals keep you satisfied longer
- Improve insulin sensitivity to stabilize blood sugar swings
- Support sustainable weight loss when paired with healthy lifestyle changes
Clinical trials show that semaglutide and tirzepatide can lead to 10 to 15 percent body weight loss within a year when combined with nutrition and exercise. It’s science-driven, not guesswork.
Introducing the Nalena program
On February 1, 2026, Nalena launched as a telehealth platform built exclusively for women navigating perimenopause, menopause, and postmenopause. Rather than a one-size-fits-all prescription, Nalena centers on your unique hormonal profile, tailoring GLP-1 medication choices and dosing schedules to how your body responds during this life stage. Licensed clinicians guide you through semaglutide or tirzepatide protocols designed to minimize side effects and maximize results.
Your journey begins with an in-depth online intake that asks about fatigue, hot flashes, sleep patterns, and medical history. This detailed questionnaire ensures your clinicians understand how menopause is affecting your metabolism and overall wellbeing.
From there, a licensed clinician crafts a plan that aligns with where you are in your hormonal transition.
Tailoring your treatment plan
Every woman’s perimenopause journey is unique, and your treatment plan should be no different. Nalena’s tailored approach ensures each variable – from hormone levels to lifestyle habits – gets the attention it deserves.
Initial health assessment
After your intake, you meet virtually with a licensed clinician who reviews your symptoms and medical background in detail. They’ll discuss how factors like stress, sleep quality, and existing health conditions interplay with GLP-1 therapy. This conversation lays the groundwork for a plan that feels personalized, not generic.
Customized dosing schedule
Based on your assessment, your clinician selects either semaglutide or tirzepatide and builds a stepwise dosing schedule to ease you into treatment. They’ll map out when to increase or maintain dosage, taking into account how your body responds to each adjustment. Regular check-ins and data tracking help fine-tune this schedule over time.
With this level of personalization, you’re more likely to see steady results and avoid common side effects.
Virtual support and check-ins
Regular accountability helps you stay on track. With Nalena, you’re not left to your own devices between prescriptions. Licensed clinicians schedule ongoing virtual check-ins to monitor your progress, discuss any side effects, and tweak your dosing as needed.
Consistency breeds success.
Beyond scheduled appointments, you also have messaging access to your care team. This means if you experience unexpected symptoms or need motivation, you can reach out without delay. Prompt responses help you maintain momentum and avoid setbacks.
Starting your journey
Getting started with Nalena is designed to be seamless and digital-first. There’s no in-person visit, which makes it easy to fit into your busy schedule.
First, head to Nalena’s website and complete the intake questionnaire, detailing your perimenopause symptoms, medical history, and lifestyle habits. From there, you’ll schedule a virtual consultation with a licensed clinician who reviews your information and discusses GLP-1 options that align with your goals.
Once you agree on a dosing plan, you commit to a minimum 12-week program. This duration has proven key to steady weight loss among women in perimenopause. Your chosen medication, semaglutide at $299 per month or tirzepatide at $399 per month, ships directly to your door. You’ll also receive detailed instructions and access for virtual check-ins.